BDBM451761 4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)-N-cyclopropyl-3-fluoro-N- methylbenzenesulfonamide::US10710978, Compound I-74

SMILES CN(C1CC1)S(=O)(=O)c1ccc(c(F)c1)-c1cnc(N)c(c1)-c1ccc2C(=O)NCc2c1

InChI Key InChIKey=VQECYUYHUIZUJQ-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 451761   

TargetSerine/threonine-protein kinase 4(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451761(4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...)
Affinity DataIC50: 40nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 3(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451761(4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...)
Affinity DataIC50: 40nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 24(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451761(4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...)
Affinity DataIC50: 900nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 26(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451761(4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...)
Affinity DataIC50: 1.00E+3nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 4(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451761(4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...)
Affinity DataIC50: 120nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 3(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451761(4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...)
Affinity DataIC50: 1.00E+3nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 24(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451761(4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...)
Affinity DataIC50: 1.00E+3nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase 26(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451761(4-(6-amino-5-(1- oxoisoindolin-5-yl)pyridin-3- yl)...)
Affinity DataIC50: 1.00E+3nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2021
Entry Details
Go to US Patent